Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RENCA macrobeads in taxane-resistant prostate cancer
NCT01174368Phase 2Completed
- Sponsor
- Rogosin Institute
- Start
- Jun 2010
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
A Phase 2 trial of RENCA macrobeads in prostate cancer (PCa), sponsored by Rogosin Institute. Started Jun 2010; status: completed.
02
Drugs
RENCA macrobeads
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01174368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174368.